Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.Link Between …
Read More »ASN: High-Dose, Proactive IV Iron Noninferior in Hemodialysis
High-dose IV iron administered proactively is noninferior to low-dose iron administered reactively
Read More »Peer Support Aids Patients With T2DM, Depressive Symptoms
Those with diabetes, depressive symptoms in peer support intervention had lower rate of hospitalization
Read More »Early Natural Menopause Linked to Shorter Life Expectancy
Early natural menopause also associated with fewer years spent living without type 2 diabetes
Read More »Inadequate Reimbursement May Mar Diabetes Prevention Program
Large gap between costs, projected reimbursement for Medicare Diabetes Prevention Program
Read More »Glucose Dysregulation Seen Years Before Diabetes Diagnosis
Fasting plasma glucose, BMI elevated 10 years before diagnosis of prediabetes, diabetes
Read More »Percent Weight Regain Predicts Health Risks Post-Bariatric Surgery
Based on long-term follow-up, percent regain after max weight loss tied to most health outcomes
Read More »Mortality Due to Suicide, Alcohol, Accidents Up in Diabetes
Patients with diabetes have higher mortality in nearly all end points, especially for insulin-treated
Read More »Sharp Drop in U.S. Life Expectancy Rankings by 2040
U.S. expected to fall from 43rd in 2016 to 64th by 2040, with an average life expectancy of 79.8
Read More »Fertility Rates Down for Each Urbanization Level 2007 to 2017
Fertility rates decreased from 2007 to 2017 with larger decreases in metro versus rural counties
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.